Clinical Trial Update: Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates [NA]

View source ↗

Summary

A completed Abbott Medical Devices trial evaluating real-time 3D echocardiography to guide left ventricular lead placement in cardiac resynchronization therapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED | Results posted: 2013-12-09